158P_PRIntermittent versus continuous chemotherapy beyond first-line for patients with HER2-negative advanced breast cancer (BOOG 2010-02)
Erdkamp, F L G, Claessens, A K M, Lopez-Yurda, M, Bouma, J M, van Tinteren, H, Rademaker-Lakhai, J M, Honkoop, A H, de Graaf, H, Tjan-Heijnen, V C G, Bos, M M E MVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz100.009
Date:
May, 2019
File:
PDF, 92 KB
english, 2019